Impax resolves FDA warning letter; Recipharm to manufacture Parkinson's drug for LobSor;

> Impax Laboratories ($IPXL) reports that it has resolved its FDA warning letter for a plant in Hayward, CA. Release

> Recipharm has reached an agreement to manufacture a proprietary treatment for advanced Parkinson's disease for Sweden-based LobSor Pharmaceuticals. Release

> The EPA has proposed a rule that would make it easier for healthcare providers to dispose of pharmaceutical waste. Blog post

> Kamani Oil Industries announced today that they have become the first Indian vegetable oil industry to get an FDA drug license for manufacture of pharmaceutical-grade oils and fats. Report

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.